The refusal to overturn an International Trade Commission (ITC) ruling has resulted in an import ban on the Apple Watch Series 9 and Apple Watch Ultra 2, based on patent violations claimed by medical device maker Masimo.
The ITC Ruling and White House Decision
Patent Infringement Leads to Ban
The ITC earlier ruled that Apple had infringed on two Masimo patents concerning blood-oxygen sensing technology. Consequently, an import ban on the Apple Watch Series 9 and Apple Watch Ultra 2 was imposed, which came into effect on December 25, 2023.
No Reprieve from the White House
Despite the opportunity to overturn the ITC's decision, the Biden administration, through U.S. Trade Representative Katherine Tai's office, confirmed on December 26 that the ruling would stand. This decision has forced Apple to remove the affected watches from its online store and physical retail locations.
Apple's Response to the Ban
Legal and Technical Challenges
Apple has not remained passive in the face of this ban. The company has filed an appeal with the Federal Circuit court seeking to overturn the ITC decision. It has also proposed a redesign of the banned models for U.S. Customs approval, requesting a temporary stay on the ban until the redesign is considered.
The Impact of the Ban
The ban has significant implications for Apple, which has expressed concerns over potential "irreparable harm" if the ban persists during the appeal process. The company has emphasized its commitment to delivering health and wellness features to its users and is exploring all avenues to bring the banned watch models back to the U.S. market.
The Broader Implications
Sales Continue Through Other Retailers
While Apple is barred from importing the new watch models, other retailers like Amazon and Best Buy are selling their remaining inventory. The low-cost Apple Watch SE remains unaffected by the ban and is still available for purchase.
A History of Patent Disputes
The conflict with Masimo is not new; the two companies have been at odds for years, with lawsuits filed on both sides. The current situation is reminiscent of a previous incident in 2013 when President Obama vetoed an ITC ruling against Apple for patent infringement involving Samsung.
Editor's Comments
The ongoing patent dispute between Apple and Masimo highlights the delicate balance between innovation and intellectual property rights. While Apple's appeal and redesign efforts reflect its resilience and commitment to its customers, the situation underscores the potential vulnerability of even the most established tech giants to patent litigation.
[Updated on Dec. 27, 2023]
Apple has successfully secured a temporary pause on the import ban for the Apple Watch. This allows the resumption of sales in Apple Stores, starting today, and on Apple.com from 3 PM ET on December 28th. The federal appeals court issued the halt in response to Apple's request, asking for a pause until the U.S. Customs determines whether changes made to the Apple Watch are sufficient to avoid the patent dispute that led to the ban. A decision from Customs is expected on January 12th.
This court order enables Apple to temporarily resume selling the Apple Watch Series 9 and Apple Watch Ultra 2, both of which were removed from the website last week and store shelves this week as the ban took effect. The ban resulted from a patent dispute with medical device maker Masimo, where the U.S. International Trade Commission found Apple to have infringed Masimo patents, leading to the sales ban. While the ban is in effect, other retailers can continue selling their existing Apple Watch stock, but Apple is restricted from selling its own watches or introducing new ones into the country.
The appeals court is currently considering a longer pause on the import and sales ban. Apple has requested the bans be halted until the appeals court issues a full ruling on the patent infringement case, a process that may take several more weeks.
Follow Us on Facebook
